Participants with diabetes had significantly higher C-reactive protein (CRP) concentrations, with the median value being in the high clinical risk category, i.e., >3 mg/L, as well as a higher percentage of HbA1c, and fasting blood glucose and fasting insulin concentrations (p < 0.0001). This evidence concerns the gene INS and diabetes mellitus.